scorecardresearch
Friday, Oct 07, 2022

DoP examining mechanism for pricing patented drugs

Department of Pharmaceuticals is examining a proposal on the pricing of patented drugs in the country.

The Department of Pharmaceuticals (DoP) is examining a proposal submitted by a committee to look into the pricing of patented drugs in the country,Parliament was informed today.

“A committee which was looking into the issue of price negotiation mechanisms for patented drugs have since submitted its report which is being examined in the department,” Minister of State for Chemicals and Fertilisers,Srikant Kumar Jena,said in a reply to a question in Rajya Sabha.

At present,there is no system of price negotiation for patented drugs,he added. Under the provisions of the Drugs Price Control Order,1995,the prices of 74 bulk drugs and formulations containing any of these scheduled drugs are controlled.

There is no control on the launch price of the non-scheduled formulations.

Subscriber Only Stories
UPSC Key-October 7, 2022: Why you should read ‘Avalanches’ or  ‘Virtual W...Premium
Blunt criticism of Russian Army signals new challenge for PutinPremium
‘If I did not explore art, my life would remain unfulfilled’: Lalu Prasad...Premium
On Budget review eve, macro worries are back amid global recession fearsPremium

“As a part of the exercise for monitoring of prices for non-scheduled formulations,manufacturers are not allowed to increase the prices of non scheduled formulations exceeding 10 per cent per annum,” the Minister said.

In case,a company increases the prices beyond 10 per cent,the specific cases are taken up by National Pharmaceutical Pricing Authority (NPPA) with the respective

companies for rolling back the increase with in the limit of 10 per cent,he added.

First published on: 17-08-2012 at 04:39:36 pm
Next Story

Excise duty hike on diesel cars soon?

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement